SGK1 inhibition induces autophagy-dependent apoptosis via the mTOR-Foxo3a pathway

Weiwei Liu1, Xuchu Wang1, Zhenping Liu2

  • 1Department of Laboratory Medicine, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou 310009, China.

British Journal of Cancer
|October 11, 2017
PubMed
Abstract

Insights

Inhibiting serum- and glucocorticoid-induced kinase 1 (SGK1) triggers cancer cell death by promoting autophagy and apoptosis through the mTOR-Foxo3a pathway, offering a novel therapeutic strategy for prostate cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Serum- and glucocorticoid-induced kinase 1 (SGK1) inhibition shows potential in delaying cancer progression.
  • The precise mechanisms underlying SGK1's role in cancer remain largely unelucidated.

Purpose of the Study:

  • To investigate the cellular mechanisms through which SGK1 inhibition exerts anti-cancer effects.
  • To explore the role of autophagy and apoptosis in SGK1 inhibition-induced cell death in prostate cancer.

Main Methods:

  • Utilized GSK650394 treatment and SGK1 silencing/overexpression in prostate cancer cell lines and xenografts.
  • Employed techniques including flow cytometry, western blotting, immunofluorescence, electron microscopy, and immunohistochemistry.

Main Results:

  • SGK1 inhibition induced G2/M arrest, apoptosis, and autophagy.
  • Autophagy induction was found to precede apoptosis, as inhibiting autophagy attenuated SGK1 inhibition-induced apoptosis.
  • Suppression of mTOR and Foxo3a phosphorylation was critical for SGK1 inhibition's effects, involving pFoxo3a (S253)-LC3 and pFoxo3a (S253)-p27 interactions.
  • Dual inhibition of mTOR and SGK1 resulted in enhanced autophagy and synergistic cytotoxic effects.

Conclusions:

  • SGK1 inhibition demonstrates significant anti-tumor effects in prostate cancer models.
  • A novel mechanism reveals SGK1 inhibition induces autophagy-dependent apoptosis via the mTOR-Foxo3a pathway.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
4.7K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.9K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
8.9K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.7K